Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9791.
-
Dexterra Group Inc. Reports Third Quarter 2026 Financial ResultsDexterra Group Inc. announced its financial results for the third quarter of 2026, reporting growth in consolidated revenue and adjusted EBITDA compared to the same period in 2025.
-
NexPoint Residential Trust Lowers Full-Year 2026 GuidanceNexPoint Residential Trust reduced its full-year Core FFO and same-store net operating income (NOI) outlook following third-quarter results.
-
Edwards Lifesciences Reports Third Quarter 2026 Financial ResultsEdwards Lifesciences announced its financial results for the third quarter ended September 30, 2026, reporting $1.72 billion in sales and adjusted earnings per share of $0.80.
-
Lyell Immunopharma Announces $80 Million Private PlacementLyell Immunopharma has entered into a securities purchase agreement to raise approximately $80 million through a private placement of its common stock.
-
Lyell Immunopharma to Present Updated Ronde-Cel Clinical Data at ASH 2026Lyell Immunopharma announced that two abstracts featuring positive updated clinical data for its ronde-cel therapy have been accepted for presentation at the 68th ASH Annual Meeting.
-
Lyell Immunopharma Reports Third Quarter 2026 Financial ResultsLyell Immunopharma released its financial results for the third quarter ended September 30, 2026, reporting a net loss of $45.5 million.
-
B. Riley Adjusts Price Target on Gladstone Commercial to $11.50B. Riley maintained a Neutral rating on Gladstone Commercial Corporation while lowering its price target from $12.50 to $11.50.
-
Stifel Maintains Buy Rating and Raises TAT Technologies Price Target to $59Stifel analyst Jonathan Siegmann has maintained a 'Buy' rating on TAT Technologies and increased the price target from $53 to $59.
-
Krispy Kreme Unveils New Holiday Doughnut CollectionKrispy Kreme has announced the launch of three new holiday-themed doughnuts to its seasonal menu.
-
EagleRock Land Enters Water Infrastructure Agreements with DEF OperatingEagleRock Land subsidiaries signed water system management and disposal agreements with DEF Operating covering approximately 35,000 acres in Texas.
-
ThredUp Announces Third Quarter 2026 Financial ResultsThredUp Inc. reported its financial results for the third quarter ended September 30, 2026, highlighting record active buyers and updated financial guidance.
-
Beacon Securities Maintains 'Buy' Rating on Maritime Launch ServicesBeacon Securities analyst Russell Stanley maintained a 'Buy' rating and $1.50 price target on Maritime Launch Services, citing the company's recent TSX listing and growing demand for launch capacity.
-
Ethan Allen Announces Preliminary Voting Results of its 2026 Annual Meeting of StockholdersEthan Allen Interiors Inc. announced preliminary results from its 2026 Annual Meeting, indicating that stockholders elected two of the company's nominees and three nominees proposed by activist investor DGB Investments to the Board of Directors.
-
Matrix Service Company Reports Fiscal 2027 First Quarter Financial ResultsMatrix Service Company announced its financial results for the first quarter of fiscal 2027, reporting revenue of $219.4 million and net income of $6.2 million.
-
Carriage Services Announces Third Quarter 2026 Financial Results and Updates GuidanceCarriage Services, Inc. reported its financial results for the third quarter ended September 30, 2026, while providing updates to its 2026 guidance and strategic acquisitions timeline.
-
Alto Ingredients, Inc. Reports Third Quarter 2026 Financial ResultsAlto Ingredients, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting positive gross profit, income from operations, net income, and adjusted EBITDA.
-
NACCO Industries Announces Third Quarter 2026 Financial ResultsNACCO Industries reported its financial results for the third quarter ended September 30, 2026, highlighting improved operating profitability and Adjusted EBITDA despite solar curtailment costs.
-
Larimar Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceLarimar Therapeutics announced that its management team will participate in a fireside chat and investor meetings at the upcoming Guggenheim 3rd Annual Healthcare Innovation Conference.
-
Immix Biopharma Announces Oral Presentation of NXC-201 Interim Clinical Trial Results at ASH 2026Immix Biopharma, Inc. will present interim clinical trial results for its lead CAR-T candidate, NXC-201, at the 68th American Society of Hematology (ASH) Annual Meeting in December 2026.
-
Allient Inc. Reports Financial Results for Third Quarter 2026Allient Inc. announced its financial results for the third quarter ended September 30, 2026, reporting record revenue and margins.